The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Intended Joint Offer for Subscription

23 Aug 2019 16:23

RNS Number : 1233K
Maven Income and Growth VCT 3 PLC
23 August 2019
 

Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC

(the "Companies")

 

Statement re Intended Joint Offers for Subscription

 

The Directors of the Companies are pleased to announce the intention to raise up to £15 million, in aggregate, by way of joint offers for subscription of new ordinary shares (the "Offers"), with shares to be issued in the 2019/20 and 2020/21 tax years.

The Boards are confident that, given the strength of the current pipeline of investment opportunities, the Companies' investment manager, Maven Capital Partners UK LLP, will continue to be able identify and complete VCT qualifying transactions in line with each Company's investment strategy.

A prospectus with full details of the Offers is intended for publication in Autumn 2019. A further announcement will be made when the prospectus is available.

An applicant will be able to invest in one or both of the Offers, in accordance with the terms to be set out in the prospectus for the Offers and subject to the relevant Offer selected remaining open.

It is anticipated that the Offers will remain open until no later than 3 April 2020 in respect of the 2019/20 tax year and until 30 April 2020 in respect of the 2020/21 tax year, unless an Offer is fully subscribed at an earlier date and subject to each Board's right to close or extend the relevant Offer at any time.

 

On behalf of the Boards

Maven Capital Partners UK LLP

Secretary

23 August 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STREASPDAAFNEFF
Date   Source Headline
10th Jul 201710:56 amRNSNet Asset Value(s)
15th Jun 20174:00 pmRNSDividend Declaration
12th May 20174:13 pmRNSTransaction in Own Shares
12th May 20174:07 pmRNSNet Asset Value(s)
11th May 20172:39 pmRNSTransaction in Own Shares
10th May 201712:33 pmRNSTransaction in Own Shares
28th Apr 20173:36 pmRNSDirectorate Change
27th Apr 20171:01 pmRNSNet Asset Value(s)
27th Apr 201712:57 pmRNSResult of AGM
24th Mar 20175:33 pmRNSAnnual Financial Report
26th Jan 20177:00 amRNSNet Asset Value and Proposed Final Dividend
20th Jan 201710:12 amRNSDirectorate Change
8th Nov 20164:49 pmRNSTransaction in Own Shares
7th Nov 201611:00 amRNSDirector/PDMR Shareholding
28th Oct 20168:39 amRNSNet Asset Value(s)
26th Aug 20164:36 pmRNSTransaction in Own Shares
21st Jul 20164:53 pmRNSHalf-year Report
13th Apr 20161:14 pmRNSDirectorate Change
13th Apr 20161:08 pmRNSResult of AGM
13th Apr 201612:52 pmRNSNet Asset Value(s)
11th Mar 20167:00 amRNSAnnual Financial Report
1st Mar 20164:14 pmRNSDirector/PDMR Shareholding
17th Feb 20165:02 pmRNSTransaction in Own Shares
10th Feb 20163:39 pmRNSForm 8.3 - Tangent Communications PLC
9th Feb 20164:41 pmRNSTransaction in Own Shares
8th Feb 201612:30 pmRNSTransaction in Own Shares
4th Feb 201610:48 amRNSTransaction in Own Shares
28th Jan 20162:47 pmRNSNet Asset Value & Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
30th Nov 201512:36 pmRNSTransaction in Own Shares
23rd Oct 201512:04 pmRNSNet Asset Value(s)
4th Sep 201510:51 amRNSPortfolio Update
24th Aug 20153:37 pmRNSStatement re Dividend Investment Scheme
10th Jul 20155:07 pmRNSHalf Yearly Report
15th Jun 20155:09 pmRNSDirector/PDMR Shareholding
12th Jun 201510:00 amRNSIssue of Equity
5th Jun 20153:17 pmRNSNet Asset Value(s)
27th May 20155:18 pmRNSTransaction in Own Shares
30th Apr 201512:43 pmRNSTransaction in Own Shares
29th Apr 20153:44 pmRNSTransaction in Own Shares
22nd Apr 20153:11 pmRNSTransaction in Own Shares
21st Apr 20153:45 pmRNSTransaction in Own Shares
16th Apr 20154:17 pmRNSNet Asset Value(s)
15th Apr 20153:16 pmRNSDirectorate Change
15th Apr 20153:13 pmRNSDirectorate Change
15th Apr 20153:12 pmRNSResult of AGM
13th Apr 20153:11 pmRNSIssue of Equity
4th Mar 20155:16 pmRNSAnnual Financial Report
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201511:24 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.